发布求助
文献互助 智能选刊 最新文献

Journal of health care law & policy最新文献

筛选
英文 中文
The Impact of Presumed Consent Legislation on Cadaveric Organ Donation: A Cross Country Study 假定同意立法对尸体器官捐献的影响:一项跨国研究
Journal of health care law & policy Pub Date : 2004-06-01 DOI: 10.2139/ssrn.562841
Alberto Abadie, S. Gay
{"title":"The Impact of Presumed Consent Legislation on Cadaveric Organ Donation: A Cross Country Study","authors":"Alberto Abadie, S. Gay","doi":"10.2139/ssrn.562841","DOIUrl":"https://doi.org/10.2139/ssrn.562841","url":null,"abstract":"In the U.S., Great Britain and in many other countries, the gap between the demand and the supply of human organs for transplantation is on the rise, despite the efforts of governments and health agencies to promote donor registration. In some countries of continental Europe, however, cadaveric organ procurement is based on the principle of presumed consent. Under presumed consent legislation, a deceased individual is classified as a potential donor in absence of explicit opposition to donation before death. This article analyzes the impact of presumed consent laws on donation rates. For this purpose, we construct a dataset on organ donation rates and potential factors affecting organ donation for 22 countries over a 10-year period. We find that while differences in other determinants of organ donation explain much of the variation in donation rates, after controlling for those determinants presumed consent legislation has a positive and sizeable effect on organ donation rates. We use the panel structure of our dataset to test and reject the hypothesis that unmeasured determinants of organ donation rates confound our empirical results.","PeriodicalId":73765,"journal":{"name":"Journal of health care law & policy","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2004-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72863321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 512
Comparing Non-Fatal Health Across Countries: Is the US Medical System Better? 比较不同国家的非致命性健康:美国的医疗系统更好吗?
Journal of health care law & policy Pub Date : 2004-02-03 DOI: 10.2139/ssrn.493644
David M. Cutler, Núria Mas
{"title":"Comparing Non-Fatal Health Across Countries: Is the US Medical System Better?","authors":"David M. Cutler, Núria Mas","doi":"10.2139/ssrn.493644","DOIUrl":"https://doi.org/10.2139/ssrn.493644","url":null,"abstract":"The primary focus of the paper is to assess whether the US, which spends significantly more than any other country in health care, has better health outcomes. It has long been clear that mortality as a whole is not better in the US than in other countries. We focus our analysis on the US performance for the treatment of non-fatal health outcomes and we compare the health of the United States to that of Canada, the United Kingdom and Spain. Our results indicate a discrepancy between high quality of life for some outcomes and low quality of life for others. Such discrepancy is not attributable to measurement issues in determining a person's quality of life, nor is it attributable to differing performance by income. Our results suggest that the discrepancy is due to the fact that the US does better for the treatment of conditions where high-tech medicine is a key to better health and worse in conditions requiring substantial chronic disease management.","PeriodicalId":73765,"journal":{"name":"Journal of health care law & policy","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2004-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90086319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
AIDS and adolescents. 艾滋病和青少年。
Journal of health care law & policy Pub Date : 2004-01-01
Rhonda Gay Hartman
{"title":"AIDS and adolescents.","authors":"Rhonda Gay Hartman","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":73765,"journal":{"name":"Journal of health care law & policy","volume":"7 2","pages":"280-315"},"PeriodicalIF":0.0,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24840181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medicate-to-execute: current trends in death penalty jurisprudence and the perils of dual loyalty. 从用药到执行:死刑法理学的当前趋势和双重忠诚的危险。
Journal of health care law & policy Pub Date : 2004-01-01
Daniel S Shaivitz
{"title":"Medicate-to-execute: current trends in death penalty jurisprudence and the perils of dual loyalty.","authors":"Daniel S Shaivitz","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":73765,"journal":{"name":"Journal of health care law & policy","volume":"7 1","pages":"149-74"},"PeriodicalIF":0.0,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40906019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bioethical malpractice: risk and responsibilities in human research. 生物伦理弊端:人类研究中的风险与责任。
Journal of health care law & policy Pub Date : 2004-01-01
Barbara A Noah
{"title":"Bioethical malpractice: risk and responsibilities in human research.","authors":"Barbara A Noah","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":73765,"journal":{"name":"Journal of health care law & policy","volume":"7 2","pages":"175-241"},"PeriodicalIF":0.0,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24840180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Matter of Priority: Transplanting Organs Preferentially to Registered Donors 优先事项:优先将器官移植给已登记的捐赠者
Journal of health care law & policy Pub Date : 2003-10-31 DOI: 10.2139/SSRN.453760
Adam J Kolber
{"title":"A Matter of Priority: Transplanting Organs Preferentially to Registered Donors","authors":"Adam J Kolber","doi":"10.2139/SSRN.453760","DOIUrl":"https://doi.org/10.2139/SSRN.453760","url":null,"abstract":"Thousands die each year in the United States alone due to a severe shortage of organs available for transplantation. In this article, I propose that we encourage people to register to donate organs upon death by offering them some priority to receive an organ should they need one during life. Such an incentive would save lives by encouraging many more people to donate, yet would not violate federal laws that prohibit organ donors from receiving financial compensation. In addition, I describe how priority incentives could, in theory, be structured to guarantee a distribution of organs that is pareto superior to our current one. I respond to critics who say that priority incentives would weaken the altruistic nature of our current donation scheme and would unacceptably commodify the human body. A fuller conception of our property interests in cadaver organs, I argue, reveals the error of elevating such organs to a special place of honor reserved for property that should be inalienable through market-style exchange.","PeriodicalId":73765,"journal":{"name":"Journal of health care law & policy","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2003-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79274271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 22
Managed Care and Undividing Loyalties 管理式医疗和忠诚
Journal of health care law & policy Pub Date : 2003-08-14 DOI: 10.2139/SSRN.407122
D. Maher
{"title":"Managed Care and Undividing Loyalties","authors":"D. Maher","doi":"10.2139/SSRN.407122","DOIUrl":"https://doi.org/10.2139/SSRN.407122","url":null,"abstract":"Managed care is often faulted for requiring physicians to abandon their traditional fiduciary responsibility to individual patients. Physician loyalty is said to be divided between a concern for patient benefit on the one hand and for financial advantages accruing to the physician personally or to the group of plan participants on the other. A recent U.S. Supreme Court case has supported this development by deciding that physicians are now responsible to function simultaneously as clinical caretakers and benefits administrators. It is granted that this situation gives rise to legitimate concerns about the potential for undermining patient trust in physicians and yet there are also reasons to believe that this is a step in the right direction. Specifically, by requiring doctors to make \"mixed\" treatment and eligibility decisions, the Court has pointed the way for people to think and make decisions about health and health care without abstracting from the cost of that care.","PeriodicalId":73765,"journal":{"name":"Journal of health care law & policy","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2003-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86993258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
General Practice Administrative and Compliance Costs 一般实践管理和合规成本
Journal of health care law & policy Pub Date : 2003-03-31 DOI: 10.2139/ssrn.402540
Productivity Commission
{"title":"General Practice Administrative and Compliance Costs","authors":"Productivity Commission","doi":"10.2139/ssrn.402540","DOIUrl":"https://doi.org/10.2139/ssrn.402540","url":null,"abstract":"The Government asked the Productivity Commission to undertake a research study examining the administrative and compliance costs associated with Commonwealth programs directed at medical general practice. The study was commissioned in July 2002. The Commission was asked to report on the nature and magnitude of these costs for individual general practitioners and general practice as a whole, and ways in which these costs may be reduced. The Commission found that general practitioners and their practices face significant costs of complying with a range of Commonwealth Government programs and provides estimates of these costs.","PeriodicalId":73765,"journal":{"name":"Journal of health care law & policy","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2003-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81914774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Do Off-Label Drug Practices Argue Against Fda Efficacy Requirements? Testing an Argument by Structured Conversations with Experts 药品说明书外操作是否与Fda功效要求相悖?通过与专家的结构化对话来验证论点
Journal of health care law & policy Pub Date : 2003-03-18 DOI: 10.2139/ssrn.425791
Daniel Klein, A. Tabarrok
{"title":"Do Off-Label Drug Practices Argue Against Fda Efficacy Requirements? Testing an Argument by Structured Conversations with Experts","authors":"Daniel Klein, A. Tabarrok","doi":"10.2139/ssrn.425791","DOIUrl":"https://doi.org/10.2139/ssrn.425791","url":null,"abstract":"The Food, Drug and Cosmetics Act of 1938 with amendments in 1962 is inconsistent regarding FDA certification of a drug’s efficacy. The act requires efficacy certification for the drug’s initial (“on-label”) uses, but does not require certification before physicians may prescribe for subsequent (“off-label”) uses. Are there good reasons for this inconsistency? Using a sequential online survey we carried on a “virtual conversation” with some 500 physicians. The survey asked whether efficacy requirements should be imposed on off-label uses, and almost all physicians said no. It asked whether the efficacy requirements for initial uses should be dropped, and most said no. We then gently challenged respondents asking them whether opposing efficacy requirements in one case but not the other involved an inconsistency. In response to this challenge we received hundreds of written commentaries. This investigation taps the specialized knowledge of hundreds of physicians and organizes their insights into challenges to the consistency argument. Thus, it employs a method of structured conversations with experts to test the merit of an argument. Is the consistency argument a case of “foolish consistency,” or does it hold up even under scrutiny?","PeriodicalId":73765,"journal":{"name":"Journal of health care law & policy","volume":"161 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2003-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73799917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Contrary to first impression, genes are patentable: should there be limitations? 与第一印象相反，基因是可以申请专利的:应该有限制吗?
Journal of health care law & policy Pub Date : 2003-01-01
Amanda S Pitcher
{"title":"Contrary to first impression, genes are patentable: should there be limitations?","authors":"Amanda S Pitcher","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":73765,"journal":{"name":"Journal of health care law & policy","volume":"6 2","pages":"284-303"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40839137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信